Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Adamis Pharmaceuticals Corporation (ADMP)

https://www.adamispharmaceuticals.com

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its products and product candidates in the allergy, respiratory, and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg and Injection 0.15mg for use in the emergency treatment of acute allergic reactions, including anaphylaxis; a naloxone injection product candidate, ZIMHI, based on the approved Symject injection device and intended for the treatment of opioid overdose; Tempol, an investigational drug; and a Beclomethasone metered dose inhaler product candidate (APC-400) intended for the treatment of Covid-19.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/14/1995

Market Cap

7,253,326

Shares Outstanding

9,360,000

Weighted SO

9,359,133

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

MNK --.--%

LFCR --.--%

LSDI --.--%

ALIM --.--%

SHPH --.--%

ORGO --.--%

CTLT --.--%

TLRY --.--%

Beta

1.2777

Last Div

0.0000

Range

0.4505-21.699999

Chg

0.0065

Avg Vol

3113594

Mkt Cap

7253326

Exch

NASDAQ

Country

US

Phone

858 997 2400

DCF Diff

-2.0200

DCF

1.1887

Div Yield

0.0000

P/S

0.5724

EV Multiple

412.4849

P/FV

-0.0011

Div Yield %

0.0000

P/E

-0.4738

PEG

-0.0175

Payout

0.0000

Current Ratio

0.5847

Quick Ratio

0.4950

Cash Ratio

0.4950

DSO

0.0000

DIO

52249.6480

Op Cycle

52249.6480

DPO

786028.9406

CCC

-733779.2926

Gross Margin

0.6345

Op Margin

-1.9995

Pretax Margin

-1.5049

Net Margin

-0.9120

Eff Tax Rate

0.3673

ROA

-0.0013

ROE

0.0093

ROCE

0.0056

NI/EBT

0.6060

EBT/EBIT

0.7526

EBIT/Rev

-1.9995

Debt Ratio

0.0071

D/E

-0.0127

LT Debt/Cap

0.0000

Total Debt/Cap

-0.0129

Int Coverage

-10.7834

CF/Debt

-0.0892

Equity Multi

-1.8042

Rec Turnover

0.0000

Pay Turnover

0.0005

Inv Turnover

0.0070

FA Turnover

0.0118

Asset Turnover

0.0014

OCF/Share

-0.7980

FCF/Share

-0.8109

Cash/Share

943.1403

OCF/Sales

-0.4449

FCF/OCF

1.0162

CF Coverage

-0.0892

ST Coverage

-0.0892

CapEx Coverage

-61.6228

Div&CapEx Cov

-61.6228

P/BV

-0.0011

P/B

-0.0011

P/S

0.5724

P/E

-0.4738

P/FCF

-1.2659

P/OCF

-0.9712

P/CF

-0.9712

PEG

-0.0175

P/S

0.5724

EV Multiple

412.4849

P/FV

-0.0011

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation